VIR
Vir BiotechnologyCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
VIR vs peer average
56/100
VIR vs. peer average (C vs. C)
Grade spread
B 1 · C 5 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GLUE is the first available peer comparator.
Monte Rosa is a closer size peer than large-cap biotech names and is useful mainly as a reminder that small-cap platform biotechs are still valued on data cadence, cash runway and partner validation rather than current product revenue; the modality is different, so the read-through is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VIR
Vir Biotechnology
GLUE
Monte Rosa Therapeutics
Grade
C
C
Momentum
63
92
Value
41
49
Sentiment
58
30
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GLUE
VIR / GLUE
Grade Position
In line
VIR vs. peer average (C vs. C)
56/100
Momentum
63
GLUEValue
41
GLUESentiment
58
VIRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VIR
GLUE is the first peer returned for this comparison set.